Search for: "ASTRAZENECA LP V APOTEX" Results 1 - 20 of 35
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
AstraZeneca Pharmaceuticals LP v. Apotex Corp. (Fed. Cir. 2012)
9 Feb 2012, 3:43 pm by Patent Docs
LP v. [read post]
Patent Docs - http://www.patentdocs.org/
Liability for Future Indirect Infringement
23 Nov 2010, 1:00 am by Jason Rantanen
By Jason Rantanen In an earlier post, I summarized the Federal Circuit's affirmance of a preliminary injunction prohibiting Apotex from marketing its generic version of AstraZeneca's budesonide in AstraZeneca LP v. [read post]
Patently-O - http://www.patentlyo.com/patent/
The Fact that FDA Required Labeling Language that Led to Direct Infringement by Consumers is not a Defense to an Inducement Claim Against Generic Drug Manufacturer
2 Feb 2011, 2:39 pm by kwbuckley
AstraZeneca LP v. [read post]
Intellectual Property Law Resources - http://ratnerprestia.com/blog/
AstraZeneca v Apotex: Affirmance of a Preliminary Injunction
4 Nov 2010, 10:59 am by Jason Rantanen
By Jason Rantanen AstraZeneca LP v. [read post]
Patently-O - http://www.patentlyo.com/patent/
Federal Circuit Draws Two Lines In Crestor ANDA Litigation
6 Mar 2012, 1:00 am by Courtenay Brinckerhoff
In AstraZeneca Pharmaceuticals LP v. [read post]
PharmaPatents - http://www.pharmapatentsblog.com
Astra v. Apotex: CAFC Affirms Non-infringement of Method of Use Claims
13 Feb 2012, 1:47 pm by Charles A. Gaglia, Jr.
LP. v. [read post]
IP Law Alert - http://www.iplawalert.com
Court Report
3 Feb 2008, 9:47 pm
Apotex Inc. v. [read post]
Patent Docs - http://www.patentdocs.org/
AstraZeneca LP v. Breath Ltd. (Fed. Cir. 2013)
13 Nov 2013, 9:14 pm by Patent Docs
The panel also affirmed the District Court's dismissal of invalidity counterclaims brought by Defendants-Cross Appellants Apotex, Inc. and Apotex Corp., and the lower court's decisions regarding the bond amount. [read post]
Patent Docs - http://www.patentdocs.org/
EDGE SYSTEMS LLC v. AGUILA: pro se appellant loses at CAFC
21 Dec 2015, 5:43 pm by Lawrence B. Ebert
” AstraZeneca LP v. [read post]
IPBiz - http://ipbiz.blogspot.com/
Asthmatic Injunction
2 Nov 2010, 1:40 am
AstraZeneca v. [read post]
Patent Prospector - http://www.patenthawk.com/blog/
Judge Robinson Grants Defendants’ Motion to Dismiss Amended Complaint in ANDA Action
23 May 2016, 7:49 am by Gregory B. Williams
  The Court reasoned that (1) like the generic in AstraZeneca Pharmaceuticals LP v. [read post]
Delaware Intellectual Property Litigation - http://delawareintellectualproperty.foxrothschild.com/
Compliance with FDA's Labeling Requirements Leads to Finding of Intent to Induce Infringement
27 May 2009, 12:44 am
"AstraZeneca LP v. [read post]
Docket Report Patent Infringement Blog - http://docketreport.blogspot.com/
District of New Jersey Considers Subject Matter Jurisdiction Where No Paragraph IV Certification Is Filed
27 Feb 2013, 9:53 pm by Aaron Barkoff
LP v. [read post]
Orange Book Blog - http://www.orangebookblog.com/
Fractured CAFC decision in Braintree v. Novel with two different dissents; case punted back to DNJ
23 Apr 2014, 7:44 am by Lawrence B. Ebert
” See also AstraZeneca LP v. [read post]
IPBiz - http://ipbiz.blogspot.com/
Judge Stark Explains Remedies for an Infringing ANDA
25 May 2012, 11:32 am by Robert Vrana
  Judge Stark cited the Federal Circuit’s recent decision in AstraZeneca Pharmaceuticals LP v. [read post]
Delaware IP Law Blog - http://www.delawareiplaw.com/
Section viii Statements -- Still A Viable Route to Generic Approval Where the Application Is Not Claimed in an Orange Book Patent
20 Apr 2012, 10:36 am by Sheppard Mullin
McGrath In its recent decision in AstraZeneca Pharmaceuticals LP v. [read post]
Intellectual Property Law Blog - http://www.intellectualpropertylawblog.com/
CAFC affirms D. Del. in Sanofi v. Watson related to generic Multaq®
11 Nov 2017, 11:00 am by Lawrence B. Ebert
See AstraZeneca LP v. [read post]
IPBiz - http://ipbiz.blogspot.com/
Pharma & Biotech Global Week in Review 25 August 2010 from IP Think Tank
25 Aug 2010, 12:37 am by Kelly
Osmotica Pharmaceutical Corp (Patent Docs) Seroquel (Quetiapine) – US: Patent infringement suit filed following Para IV certification: Astrazeneca Pharmaceuticals LP et al. v. [read post]
IP Thinktank - http://duncanbucknell.com/ipthinktank.blog
Pharma & Biotech Global Week in Review 1 December 2010 from IP Think Tank
1 Dec 2010, 12:15 am by Kelly
Navinta LLC (Property, intangible) Pulmicort Respules (Budesonide) – US: Liability for future indirect infringement: AstraZeneca LP v. [read post]
IP Thinktank - http://duncanbucknell.com/ipthinktank.blog
LA BioMed’s Patent Case against Cialis Revived by Federal Circuit
28 Feb 2017, 7:39 am by Dennis Crouch
 The particular claims require “a continuous long term regimen . . . at a dosage up to 1.5 mg/kg/day for not less than 45 days” for treating “an individual with … penile tunical fibrosis …” On anticipation, the court drew a fine-line with its closest case being AstraZeneca LP v. [read post]
Patently-O - http://patentlyo.com/patent